Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medolexin 250 mg capsules hard.
Medolexin 500 mg capsules hard.
| Pharmaceutical Form |
|---|
|
Capsule. Black-green hard gelatine capsules. |
Each Medolexin 250 mg capsule contains cefalexin monohydrate equivalent to cefalexin base 250 mg.
Each Medolexin 500 mg capsule contains cefalexin monohydrate equivalent to cefalexin base 500 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Cefalexin |
Cefalexin is an antibacterial agent of the cephalosporin class. Like other cephalosporins cefalexin exerts antibacterial activity by binding to and inhibiting the action of penicillin-binding proteins involved in the synthesis of bacterial cell walls. This leads to bacterial cell lysis and cell death. |
| List of Excipients |
|---|
|
Medolexin capsules: magnesium stearate, gelatine, titanium dioxide (E171), iron oxide black (E172), iron oxide yellow (E172) and indigo carmine (E132). |
Medolexin 250mg capsules: PVC-Aluminium blisters in carton packs of 16, 20 and 100 capsules.
Medolexin 500mg capsules: PVC-Aluminium blisters in carton packs of 10, 16, 20 and 100 capsules.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medolexin 250 mg capsules: 19894
Medolexin 500 mg capsules: 19895
Medolexin 250 mg capsules:
Date of first authorisation: 28.12.2005
Date of latest renewal: 26.08.2013
Medolexin 500 mg capsules:
Date of first authorisation: 28.12.2005
Date of latest renewal: 21.08.2013
| Drug | Countries | |
|---|---|---|
| MEDOLEXIN | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
